Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
- Authors: Smirnova E.Y.1
-
Affiliations:
- City Clinic №. 44
- Issue: Vol 30, No 12 (2023)
- Pages: 138-141
- Section: Clinical case
- URL: https://journals.eco-vector.com/2073-4034/article/view/626064
- DOI: https://doi.org/10.18565/pharmateca.2023.12.138-141
- ID: 626064
Cite item
Open Access
Access granted
Abstract
Description of the clinical case. A clinical case of a patient with decompensated type 2 diabetes mellitus (DM2) is presented. The patient was not followed-up for a long time after diagnosis and prescription of therapy; did not follow the diet; independently discontinued prescribed medications; and did not control the glycemic level. It is thise type of patients that outpatient doctors have to deal with. It is important to assess the status of missed opportunities to correct the glycemic profile; assess the development of complications of DM2 and select adequate and comfortable therapy. The glycemic control using a diary before and after a change in therapy; and laboratory parameters were assessed in the patient.
Conclusion. Gosogliptin therapy has proven its effectiveness and safety in patients with decompensated DM2.
Full Text
About the authors
Ekaterina Yu. Smirnova
City Clinic №. 44
Author for correspondence.
Email: katrin_cat@list.ru
ORCID iD: 0000-0003-2487-0038
Endocrinologist
Russian Federation, St. PetersburgReferences
- Дедов И.И.; Шестакова М.В.; Викулова О.К. и др. Атлас регистра сахарного диабета Российской Федерации. Статус 2018 г. Сахарный диабет. 2019;22(Suppl. 2):4–61. [Dedov I.I.; Shestako-va M.V.; Vikulova O.K. et al. Atlas of the diabetes registry of the Russian Federation. Status 2018. Diabetes mellitus. 2019;22(Suppl. 2):4–61. (In Russ.)]. doi: 10.14341/DM12208.
- McKnight J.A.; et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diab Med. 2015;32:1036–50. doi: 10.1111/dme.12676.
- Oguz A.; Benroubi M.; Brismar K.; et al. Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study. Curr Med Res Opin. 2013;29:911–20. doi: 10.1185/03007995.2013.803053.
- Polinski J.M.; Kim S.C.; Jiang D.; et al. Geographic patterns in patient demographics and insulin use in 18 countries; a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIcBMC). Endocr Disord. 2015;15:46. doi: 10.1186/s12902-015-0044-z.
- Дедов И.И.; Шестакова М.В.; Майоров А.Ю. и др. «Алгоритмы специализированной медицинской помощи больным сахарным диабетом» (10й выпуск). Под ред. И.И. Дедова; М.В. Шестаковой; А.Ю. Майорова. Cахарный диабет. 2021;(Suppl. 1):1–148. [Dedov I.I.; Shestakova M.V.; Mayor-ov A.Yu. and others. “Algorithms for specialized medical care for patients with diabetes mellitus” (10th issue). Ed. by I.I. Dedov; M.V. Shestakova; A.Yu. Mayorov. Diabetes mellitus. 2021;(Suppl. 1):1–148. (In Russ.)]. doi: 10.14341/DM12802.
Supplementary files
